American Oriental Bioengineering, Inc.
AOBI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$949
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $949.00 |
|---|---|
| Enterprise Value | $101.88 Million |
| Earnings per Share | $-781.24 |
| Beta | 0.2 |
| Outstanding Shares | 72,933 |
Return
| Return on Equity | -32.09% |
|---|---|
| Return on Assets | -21.28% |
| Return on Invested Capital | -27.73% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.84 |
| Enterprise Value to EBIT | -1.22 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.03 |
| Debt to Equity | 0.37 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About American Oriental Bioengineering, Inc.
3,719 employees
CEO: Shujun Liu
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's ...